These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9728805)

  • 1. Serum erythropoietin levels in patients with leukemia on cytostatic treatment.
    Aydogdu I; Ilhan O; Beksac M; Koc H; Akan H; Konuk N; Uysal A
    Haematologia (Budap); 1998; 29(2):133-7. PubMed ID: 9728805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological and biochemical changes in acute leukemic patients after chemotherapy.
    Rasheed A; Iqtidar A; Khan S
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):207-8. PubMed ID: 9812735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on serum erythropoietin levels in patients with hematologic malignancies].
    Han B; Shi YK; Zhu J; He XH; Lin NJ; Li SL; Shen T
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):543-5. PubMed ID: 17172129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
    Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
    Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Large granule-containing lymphocytes in patients with acute leukemia].
    Gashchuk AP; Kindzel'skiĭ AL
    Vrach Delo; 1989 Jul; (7):10-1. PubMed ID: 2800475
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood coagulation factors and proteinase inhibitors in cytostatic therapy of acute leukemia].
    Anders O; Nagel HR; Ernst B; Konrad H; Zgola M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):769-80. PubMed ID: 2465258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of extracellular DNA and polyamines as criteria of resistance to chemotherapy in patients with acute leukemia].
    Kovtunova ME; Pan'kov VN; Vorozhtsova SI; Riabova TI; Tselousova OM
    Vopr Med Khim; 1990; 36(5):83-5. PubMed ID: 2251804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
    Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL
    Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
    Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
    Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults].
    Li QH; DU X; Huang ZL; Luo CW; Zhong LY; Lin W
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1195-7. PubMed ID: 16029595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma ammonia in patients with acute leukemia.
    Xu SR; Yao EG; Dong ZR; Liu RS; Pan L; Lin FR; Zhang RX; Liu MC; Ma BB; Yin JQ
    Chin Med J (Engl); 1992 Sep; 105(9):713-6. PubMed ID: 1288971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction.
    Ferrario M; Massa M; Rosti V; Campanelli R; Ferlini M; Marinoni B; De Ferrari GM; Meli V; De Amici M; Repetto A; Verri A; Bramucci E; Tavazzi L
    Eur Heart J; 2007 Aug; 28(15):1805-13. PubMed ID: 17412728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.